Diabetes Drug Face-Off: New Japanese Trial Tests Whether a Popular SGLT2 Inhibitor Eats Away at Muscle
A Japanese randomized trial will compare the SGLT2 inhibitor tofogliflozin with glimepiride to determine whether popular diabetes drugs erode skeletal ...

